A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer

Project description

Experimental vaccine for the treatment of Chordoma and head and neck cancer

Fields of science

• medical and health sciences › basic medicine › immunology › immunotherapy
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines
• medical and health sciences › clinical medicine › oncology › head and neck cancer

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

MAXIVAX SA

Address

Avenue De Sécheron 15
1202 Geneva
Switzerland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 785 300